Article Type
Article
Changed
Wed, 12/12/2018 - 19:32
Display Headline
Efficacy and Emergent Sequelae in the Use of Biologics for Psoriasis
Author(s)
Stephen M. Schleicher, MD

Article PDF
042040006.pdf
Author and Disclosure Information

Stephen M. Schleicher, MD

Issue
Emergency Medicine - 42(4)
Publications
Emergency Medicine
MDedge Emergency Medicine
Topics
Dermatology
Page Number
6-11
Legacy Keywords
biologics, psoriasis, psoriatic arthritis, T cells, alefacept, adalimumab, etanercept, golimumab, infliximab, ustekinumab, ABT-874biologics, psoriasis, psoriatic arthritis, T cells, alefacept, adalimumab, etanercept, golimumab, infliximab, ustekinumab, ABT-874
Sections
Clinical Review
Author(s)
Stephen M. Schleicher, MD
Author(s)
Stephen M. Schleicher, MD
Author and Disclosure Information

Stephen M. Schleicher, MD

Author and Disclosure Information

Stephen M. Schleicher, MD

Article PDF
042040006.pdf
Article PDF
042040006.pdf

Issue
Emergency Medicine - 42(4)
Issue
Emergency Medicine - 42(4)
Page Number
6-11
Page Number
6-11
Publications
Emergency Medicine
MDedge Emergency Medicine
Publications
Emergency Medicine
MDedge Emergency Medicine
Topics
Dermatology
Article Type
Article
Display Headline
Efficacy and Emergent Sequelae in the Use of Biologics for Psoriasis
Display Headline
Efficacy and Emergent Sequelae in the Use of Biologics for Psoriasis
Legacy Keywords
biologics, psoriasis, psoriatic arthritis, T cells, alefacept, adalimumab, etanercept, golimumab, infliximab, ustekinumab, ABT-874biologics, psoriasis, psoriatic arthritis, T cells, alefacept, adalimumab, etanercept, golimumab, infliximab, ustekinumab, ABT-874
Legacy Keywords
biologics, psoriasis, psoriatic arthritis, T cells, alefacept, adalimumab, etanercept, golimumab, infliximab, ustekinumab, ABT-874biologics, psoriasis, psoriatic arthritis, T cells, alefacept, adalimumab, etanercept, golimumab, infliximab, ustekinumab, ABT-874
Sections
Clinical Review
Article Source

PURLs Copyright

Inside the Article

Article PDF Media